fda semaglutide warning november 2025 Letter Breakdown: Sterility Failures, Subpotent GLP-1 Drugs, and a Compounding Pharmacy Operating Without Control Novo Nordisk Seeks FDA Approval

Soaring in popularity, GLP-1 medications from weekly injections to newly available pills are rapidly reshaping how Americans think about weight loss

The Standard Appearance of Semaglutide To understand why a medication might appear red, it is helpful to first establish what the standard version looks like

This may be caused by electrolyte imbalances, dehydration, blood sugar fluctuations, stress, fatigue, and medication interactions

The question of combining GLP-1 medications with other weight management approaches comes up frequently

For many patients, the most valuable benefit is the ability to maintain progress without constantly feeling hungry or stuck in a cycle of losing and regaining weight

Needle anxiety is one of the most common concerns patients raise before starting injectable medications-and its one that nearly everyone moves past within the first few weeks